Downloads: 1
202 lines (201 with data), 7.2 kB
T1 Age 2 13 23-year-old T2 Sex 14 19 woman T3 Disease_disorder 38 58 carnitine deficiency E1 Disease_disorder:T3 T4 History 38 58 carnitine deficiency T5 Sign_symptom 85 92 dyspnea E2 Sign_symptom:T5 T6 Sign_symptom 97 104 fatigue E3 Sign_symptom:T6 T7 Detailed_description 74 84 exertional R1 MODIFY Arg1:T7 Arg2:E2 T8 Disease_disorder 147 161 cardiomyopathy E4 Disease_disorder:T8 T9 Age 165 177 age 10 years T10 Detailed_description 135 146 nonischemic R2 MODIFY Arg1:T10 Arg2:E4 T11 Disease_disorder 226 239 heart failure E5 Disease_disorder:T11 T12 Detailed_description 215 225 congestive R3 MODIFY Arg1:T12 Arg2:E5 T13 Diagnostic_procedure 244 274 transthoracic echocardiography E6 Diagnostic_procedure:T13 T14 Diagnostic_procedure 276 279 TTE E7 Diagnostic_procedure:T14 R4 IDENTICAL Arg1:E7 Arg2:E6 T16 Disease_disorder 315 317;319 330 LV dysfunction E8 Disease_disorder:T16 T15 Disease_disorder 297 313;319 330 left ventricular dysfunction E9 Disease_disorder:T15 R5 IDENTICAL Arg1:E8 Arg2:E9 T17 Severity 290 296 severe R6 MODIFY Arg1:T17 Arg2:E9 R7 MODIFY Arg1:E9 Arg2:E7 T18 Sign_symptom 203 211 symptoms E10 Sign_symptom:T18 R8 MODIFY Arg1:E5 Arg2:E10 T19 Diagnostic_procedure 350 371 total carnitine level E11 Diagnostic_procedure:T19 T20 Lab_value 376 385 <3 μmol/L R9 MODIFY Arg1:T20 Arg2:E11 T21 Diagnostic_procedure 424 444 free carnitine level E12 Diagnostic_procedure:T21 T22 Lab_value 449 458 <3 μmol/L R10 MODIFY Arg1:T22 Arg2:E12 * OVERLAP E11 E8 E12 E15 * OVERLAP E5 E6 T23 Date 165 177 age 10 years E13 Date:T23 * OVERLAP E13 E10 E4 T24 Disease_disorder 526 546 carnitine deficiency E14 Disease_disorder:T24 T25 Disease_disorder 493 507 cardiomyopathy E15 Disease_disorder:T25 R11 CAUSE Arg1:E14 Arg2:E15 T26 Duration 554 562 5 months E16 Duration:T26 T27 Medication 579 600 carnitine supplements E17 Medication:T27 * OVERLAP E16 E17 T28 Diagnostic_procedure 606 621;641 647 total carnitine levels E18 Diagnostic_procedure:T28 T29 Diagnostic_procedure 626 647 free carnitine levels E19 Diagnostic_procedure:T29 T30 Lab_value 665 674 86 μmol/L T31 Lab_value 679 688 48 μmol/L R12 MODIFY Arg1:T30 Arg2:E18 R13 MODIFY Arg1:T31 Arg2:E19 T32 Diagnostic_procedure 729 746 systolic function E20 Diagnostic_procedure:T32 T33 Biological_structure 712 728 left ventricular R14 MODIFY Arg1:T33 Arg2:E20 T34 Lab_value 793 798 34.7% T35 Medication 929 957 carnitine supplement regimen E21 Medication:T35 T36 Detailed_description 895 919 intermittently compliant R15 MODIFY Arg1:T36 Arg2:E21 T37 Date 983 1011 6 months before presentation E22 Date:T37 T38 Diagnostic_procedure 1037 1058 free carnitine levels E23 Diagnostic_procedure:T38 T39 Diagnostic_procedure 1017 1032;1052 1058 total carnitine levels E24 Diagnostic_procedure:T39 T40 Lab_value 1074 1083 18 μmol/L T41 Lab_value 1088 1097 17 μmol/L R16 MODIFY Arg1:T40 Arg2:E24 R17 MODIFY Arg1:T41 Arg2:E24 T42 Diagnostic_procedure 768 789 fractional shortening E25 Diagnostic_procedure:T42 T43 Lab_value 751 761 normalized R19 BEFORE Arg1:E17 Arg2:E18 * OVERLAP E18 E19 E20 R20 SUB_PROCEDURE Arg1:E25 Arg2:E20 R21 MODIFY Arg1:T43 Arg2:E20 R22 MODIFY Arg1:T34 Arg2:E25 T44 Duration 853 875 over the past 10 years E26 Duration:T44 * OVERLAP E26 E21 T46 Clinical_event 815 824 admission E28 Clinical_event:T46 T47 Diagnostic_procedure 1127 1130 TTE E29 Diagnostic_procedure:T47 T48 Diagnostic_procedure 1143 1169 cardiac magnetic resonance E30 Diagnostic_procedure:T48 T49 Diagnostic_procedure 1171 1174 CMR E31 Diagnostic_procedure:T49 R23 IDENTICAL Arg1:E31 Arg2:E30 R25 BEFORE Arg1:E29 Arg2:E30 T51 Diagnostic_procedure 1227 1238 LV function E32 Diagnostic_procedure:T51 T52 Diagnostic_procedure 1209 1212 TTE E33 Diagnostic_procedure:T52 T53 Lab_value 1220 1226 normal R26 MODIFY Arg1:T53 Arg2:E32 R27 SUB_PROCEDURE Arg1:E32 Arg2:E33 T54 Disease_disorder 1260 1274 LV hypertrophy E34 Disease_disorder:T54 T55 Detailed_description 1249 1259 concentric T56 Severity 1243 1247 mild R28 MODIFY Arg1:T56 Arg2:E34 R29 MODIFY Arg1:T55 Arg2:E34 R30 MODIFY Arg1:E34 Arg2:E33 T57 Diagnostic_procedure 1316 1323 LV size E35 Diagnostic_procedure:T57 T58 Lab_value 1309 1315 normal R32 MODIFY Arg1:T58 Arg2:E35 T59 Diagnostic_procedure 1316 1318;1328 1336 LV function E36 Diagnostic_procedure:T59 * OVERLAP E36 E35 E37 R33 MODIFY Arg1:T58 Arg2:E36 T60 Diagnostic_procedure 1364 1378 wall thickness E37 Diagnostic_procedure:T60 T61 Lab_value 1354 1363 increased R34 MODIFY Arg1:T61 Arg2:E37 T62 Biological_structure 1386 1391;1408 1412 basal wall T63 Biological_structure 1396 1412 mid lateral wall R35 MODIFY Arg1:T62 Arg2:E37 R36 MODIFY Arg1:T63 Arg2:E37 T64 Diagnostic_procedure 1414 1437 end-diastolic thickness E38 Diagnostic_procedure:T64 T65 Distance 1439 1445 1.6 cm R37 MODIFY Arg1:T65 Arg2:E38 T66 Diagnostic_procedure 1467 1497 delayed gadolinium enhancement E39 Diagnostic_procedure:T66 T67 Disease_disorder 1555 1575 sudden cardiac death E40 Disease_disorder:T67 T68 Family_history 1555 1575 sudden cardiac death T69 Diagnostic_procedure 1586 1606 myocardial structure E41 Diagnostic_procedure:T69 T70 Lab_value 1577 1585 abnormal R38 MODIFY Arg1:T70 Arg2:E41 T71 Family_history 1577 1606 abnormal myocardial structure T72 Disease_disorder 1612 1638 underlying disease process E42 Disease_disorder:T72 T73 Family_history 1612 1638 underlying disease process T74 Therapeutic_procedure 1655 1693 implantable cardioverter-defibrillator E43 Therapeutic_procedure:T74 T75 Detailed_description 1642 1654 dual-chamber R39 MODIFY Arg1:T75 Arg2:E43 T50 Diagnostic_procedure 1181 1203 gadolinium enhancement E44 Diagnostic_procedure:T50 R24 SUB_PROCEDURE Arg1:E44 Arg2:E31 R40 AFTER Arg1:E28 Arg2:E26 R41 BEFORE Arg1:E21 Arg2:E22 * OVERLAP E22 E24 E23 R42 BEFORE Arg1:E24 Arg2:E29 T76 History 135 161 nonischemic cardiomyopathy T77 History 203 211 symptoms T78 History 215 239 congestive heart failure T79 History 244 274 transthoracic echocardiography T80 History 290 330 severe left ventricular (LV) dysfunction T81 History 350 371 total carnitine level T82 History 424 444 free carnitine level * OVERLAP E2 E3 T83 History 493 507 cardiomyopathy T84 History 526 546 carnitine deficiency R18 BEFORE Arg1:E14 Arg2:E16 T85 History 579 600 carnitine supplements T86 History 606 621;641 647 total carnitine levels T87 History 626 647 free carnitine levels T88 History 712 746 left ventricular systolic function T89 History 768 789 fractional shortening T90 Detailed_description 1348 1353 focal R43 MODIFY Arg1:T90 Arg2:E37 R44 BEFORE Arg1:E25 Arg2:E28 T45 Diagnostic_procedure 1295 1298 CMR E27 Diagnostic_procedure:T45 #1 AnnotatorNotes E33 Should label as coreference if referring to previously mentioned TTE? R31 AFTER Arg1:E44 Arg2:E33 * OVERLAP E33 E29 R45 BEFORE Arg1:E33 Arg2:E27 * OVERLAP E27 E31 #2 AnnotatorNotes E27 Should label as coreference if refer to previous CMR? R46 SUB_PROCEDURE Arg1:E36 Arg2:E27 R47 SUB_PROCEDURE Arg1:E35 Arg2:E27 R48 SUB_PROCEDURE Arg1:E37 Arg2:E27 R49 SUB_PROCEDURE Arg1:E38 Arg2:E37 T91 Detailed_description 1460 1466 patchy R50 MODIFY Arg1:T91 Arg2:E39 R51 SUB_PROCEDURE Arg1:E39 Arg2:E37 R52 BEFORE Arg1:E39 Arg2:E43 R53 BEFORE Arg1:E1 Arg2:E2